San Diego Personal Injury Blog

By Allison Sampite-Montecalvo – U-T San Diego

CHULA VISTA — The deadline for some Chula Vista residents to file claims against the city for refunds on their cellphone bills has been extended.

Education

Law School/Year: University of San Diego, 1983

College/Year: University of San Diego, 1980

Bar Admissions

California

Practice Areas

Serious Personal Injury; Head/Brain Injury; Property Damage

Major Cases

Super Lawyers has recognized six CaseyGerry partners – David Casey Jr., Gayle M. Blatt, Robert J. Francavilla, Thomas D. Luneau, Thomas D. Penfield and Frederick Schenk – in its prestigious annual ranking of attorneys. 

As we head into the dog days of August, don’t get complacent about your kids and their safety!

Unfortunately, summer is a dangerous time of year for youngsters. Children have more free time and are less supervised during summer months, so tragedies peak.

The attorneys at CaseyGerry specialize in serious personal injury and traumatic brain injury cases, and are at the forefront of the complex medical issues related to brain injury. These include chronic traumatic encephalopathy, a degenerative brain disease thought to be caused by repeat concussions or blows to the head, and second impact syndrome, a condition in which the brain swells rapidly after a person suffers a second concussion.

Asbestos has killed hundreds of thousands of people and injured millions more. In fact, an estimated 1.3 million workers may end up with deadly diseases – including mesothelioma, asbestosis or lung cancer – as a result of exposure to this toxic product.

The legal battles related to labeling for generic drugs rage on.

In 2011, The United States Supreme Court decision, PLIVA, Inc., et al. v. Mensing, gave more power to drug companies – ruling that generic makers cannot be held responsible for failure to warn about a drug’s side-effects, since the generic maker is only making a “copy” of the brand drug and must follow the brand name’s label.

By Patricia L. Zlaket, CaseyGerry – Published 7/19/13 in the Daily Journal

Unfortunately for millions of consumers, the legal battles related to labeling for generic drugs rage on.

In 2011, the U.S.